COMMERCIALRADIOPHARMACYNETWORK

Jubilant Pharma is a Partner of Choice for R&D, manufacture and supply ofGenerics - Dosage Formulations and APIs, Specialty Pharmaceuticals –

Radiopharmaceuticals, Allergy Therapy Products and Contract Manufacturing of

Sterile Injectables. We have Business partnerships in over 65 countries.

Corporate Office: 1A, Sector 16A, Noida - 201301, U.P., INDIA

Tel: +91 120 4361000 Fax: +91 120 2516628

Tel.: 1-888-633-5343 or 514-630-7080 Fax: 1-866-431-4288 or 514-694-3865

You can also write to us for business specific inquiries at: customerservice@jdi.jubl.com

To know more log on to: www.jubilantpharma.com

ubilant Life Sciences, through its subsidiary, Jubilant

JPharma, operates a Commercial Radiopharmacy Network, Jubilant DraxImage Radiopharmacies. With more than 30 years of experience in preparing

radioisotopes, Jubilant DraxImage Radiopharmacies, is a

nuclear pharmacy network with a team of highly skilled

nuclear pharmacists delivering the specialized expertise

and customized solutions critical to supporting and

enhancing the nuclear medicine industry.

Headquartered in Orlando, Florida, Jubilant DraxImage

Radiopharmacies operates a nationwide network of nuclear

pharmacies in the USA. Fifty-one (51) locations provide

single photon emission computed tomography (SPECT)

prescriptions and three have on-site cyclotrons that provide

positron emission tomography (PET) products. Together,

those locations serve 4 million patients each year, making

Jubilant DraxImage Radiopharmacies the second-largest

nuclear pharmacy company in the United States.

Jubilant DraxImage Radiopharmacies offers a wide

spectrum of Nuclear Medicine products that provide safe

and cost-effective ways to image the body and treat

disease. The pharmacies are “open formulary”, providing

customers with a full array of radiopharmaceutical options.

This allows clinicians to select the products they prefer to

achieve the highest benefit for their patients. Multi-source

arrangements for key products — such as Tc99m

Generators, Sestamibi, Technetium and Thallium — help

ensure supply availability.

In accordance with State Board of Pharmacy regulations,

prescription orders are required for all radiopharmaceutical

products dispensed by Jubilant DraxImage

Radiopharmacies. Prior to delivery, a specially trained team

member performs radiopharmaceutical quality assurance

testing (QC) on every compounded preparation before it

leaves the pharmacy.

Jubilant DraxImage Radiopharmacies procures and

supplies only FDA-approved sterile injectable

radiopharmaceutical products and fully supports USP

compounding standards during compounding and

dispensing.

Jubilant DraxImage Radiopharmacies’ Institute of Learning

is dedicated to advancing the field of Nuclear Medicine

through education, research, publishing and identification

of innovative best practices. The Institute draws from the

thought leadership of Jubilant DraxImage

Radiopharmacies, including clinicians, technologists,

nuclear pharmacists and other professionals, who together

bring decades of experience in SPECT, PET imaging,

including the regulatory expertise as part of the Jubilant

DraxImage Radiopharmacies team. Through the Institute,

the team of subject matter experts are available to consult

on clinical and technical issues related to nuclear agents

and provide guidance on regulatory mandates.

On-Going “Live” CE (Continuing Education) courses are

presented by the Institute's fully certified Strategic

Teaching and Training (S.T.A.T.) Team comprised of nuclear

pharmacists, technicians, and quality and safety

professionals, as well as certified representatives of our

industry partners. Many CE courses are also available as

free, on-demand courses through our Online Learning

Center.

Jubilant DraxImage Radiopharmacies, Inc. is currently

doing business as Triad Isotopes.

For More Information:www.triadisotopes.com